Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-mefloquine versus Coartem dispersible for uncomplicated falciparum malaria in African children
PACTR201202000278282Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Randomised trial of artesunate, mefloquine, artemether and lumefantrine in Malaria (2 arms), sponsored by Drugs for Neglected Diseases initiative. Primary endpoint: PCR-corrected adequate clinical and parasitological response. Started Dec 2010; status: completed.
02
Drugs
artesunatemefloquineartemetherlumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201202000278282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201202000278282.